Aspire Biopharma (ASBP)

• Market cap: $9.95M
• 1 day: -1.41%
• 5 days: 6.22%
• 1 month: 28.64%
• 3 months: 39.13%
• 6 months: -81.04%
• Year to date: -95.33%
• 1 year: -98.25%
• 5 years: -99.94%
• 10 years: -99.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.